News filed under Clinical Trial Update, newest first.
Showing 1–5 of 10 stories
Latest story
The agreement grants Nxera exclusive development and commercialization rights for the investigationa...
Read story
Late-breaking data presented at ACR Convergence 2026 show that investigational URAT1 inhibitor pozde...
Read story
Mundipharma has announced additional results from the Phase 3 ReSPECT clinical trial evaluating Rezz...
Read story
Roche has announced positive Phase III results from the ongoing IMAgINATION study evaluating investi...
Read story
Two-year VISIONARY results showed a 97.1% lower risk of composite kidney outcome events and sustaine...
Read storyPage 1 of 2